With the support of Dedalus, all 6 of the Al Mouwasat Medical Services Company hospitals in Saudi Arabia have accomplished the highest possible stage of the HIMSS EMRAM. As a healthcare provider for over 40 years, Al Mouwasat Medical Services Company knows that to continue providing quality healthcare and medical services, they need to be at the forefront of medical technology. The investment in Dedalus’ innovative IT healthcare solutions has eliminated inefficiencies in the delivery of health services and is a hugely contributing factor in achieving stage 7 of the HIMSS EMRAM.

“It’s really great to be accredited with HIMSS Stage 7. For us, it shows that we are playing at the top of the game in healthcare and quality. Our clinical staff are aligned on how to implement the best practices across all streams related to the patient experience. We have created a culture where our staff are more aware on how to keep the continuous enhancement up and running, which has resulted in significant outcomes” Thamer Al Momani, Chief Information Officer Al Mouwasat.

Al Mouwasat partnered with Dedalus with the integration of Dedalus’ Enterprise Management (EM) system, which connects everything from patient demographics to clinical data and financial reports. Information is delivered exactly where it needs to be, creating a seamless flow of connectivity between every aspect of the patient healthcare journey. This system ensures the continuation of patient safety and overall satisfaction throughout the patient journey, it also safeguards patient and hospital data, supporting the workflow and content in digital tools to meet the needs of clinical teams.

Since the integration of Dedalus’ EM system into the hospitals in 2016, Dedalus have supported the achievement of HIMSS EMRAM score of 7 across all 6 of the Al Mouwasat hospitals. This was first achieved in Al Mouwasat’s newest and 100% paperless Khobar hospital in September 2020. The hospitals in Riyadh, Dammam and Qatif achieved the score of 7 in March 2021 and the most recent achievement came on 8th August 2021 where a HIMSS EMRAM score of 7 was achieved in the final two hospitals in Jubail and Madinah. Only a few organisations have achieved stage 7 status, as it is the highest level an organisation can achieve, and are among an elite group of healthcare organisations.

Phil Humber, Managing Director of Dedalus Middle East and Africa stated that, “Achieving stage 7 on the EMRAM scale across multiple facilities is no small feat. Al Mouwasat have demonstrated their forward thinking and relentless drive for healthcare delivery excellence. As their technology partner, we are thrilled to have been a key component of that journey.” Al Mouwasat has an aim of shaping itself into a healthcare chain that delivers the most comprehensive services to patients throughout the KSA, in addition to establishing itself as a dominant force of healthcare provisions across the Middle East region. This is certainly well on the way to being achieved with this HIMSS acknowledgement of excellence.

-Ends-

About HIMMS:

The Healthcare Information and Management Systems Society (HIMSS) is an American Not-for-profit organisation dedicated to improving the quality, safety, cost-effectiveness and accessibility of health care through the best use of information technology management systems. The HIMSS Analytics Electronic Medical Record Adoption Model (EMRAM) score hospitals around the world relative to their Electronic Medical Record (EMR) capabilities, using eight stages from 0-7. In order to reach the highest stage of the model, hospitals are required to be completely paperless, make use of discrete data, document and medical images to manage and deliver patient care. Data warehousing to analyse patterns of clinical data and demonstrate summary data continuity across all hospital services. Any clinical information can be readily shared via electronic transaction throughout all entities of the patient journey. Closed-loop processes that integrate automated and intelligent systems must reach 95%.

About Dedalus:

Founded in Florence, 1980, Dedalus' meteoric progression attracted Ardian, Europe's largest private equity fund, resulting in them becoming majority shareholders. In 2020 Dedalus bought a large portion of Agfa HealthCare’s IT business and by 2021, Dedalus acquired DXC Healthcare IT and now has the global capacity to support innovation. Most recently ADIA invested in a significant minority stake to support "a key international player in the market". From supporting private facilities in Saudi Arabia achieve HIMSS EMRAM 7, to rolling out a solution that provides for 2.7 million of Egyptian citizens. Dedalus has successfully implemented 120 solutions across the region and is invested in developing local teams across the GCC. Currently, there are 347 live facilities in the Middle East and Africa using Enterprise Management solutions.

Contact: Ashleigh Tarmey
Phone: (+971) 589 215 300
Email: ashleigh.tarmey@dxc.com 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.